Clinical Trial Update: Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates the evaluation of an IDO inhibitor in combination with temozolomide for adult malignant brain tumors, including glioblastoma and glioma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma
• Malignant Brain Tumor

Drugs mentioned

• IDO inhibitor (indoleamine 2,3-dioxygenase inhibitor)
• Temozolomide (Temozolomide)

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Glioblastoma Multiforme, Glioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-03-27